On May 14, 2021 NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase"), a biotechnology company accelerating the genetic revolution with a new class of precision genetic medicines, reported that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will participate in a virtual fireside chat at the RBC Capital Markets Virtual Global Healthcare Conference, as well as present a corporate overview and business update at the Oppenheimer Rare & Orphan Disease Summit, which are both being held in May 2021 (Press release, NeuBase Therapeutics, MAY 14, 2021, View Source [SID1234580017]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conferences Details:

Event: RBC Capital Markets Virtual Global Healthcare Conference
Format: Fireside Chat
Date: Wednesday, May 19th
Time: 11:30 a.m. ET
Location: Webcast Link – or at the company’s website (click here)

Event: Oppenheimer Rare & Orphan Disease Summit
Format: Presentation
Date: Friday, May 21st
Location: Webcast Link – or at the company’s website (click here)